Related Experiment Video

Updated: Aug 6, 2026

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice
08:13

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice

Published on: April 10, 2019

Therapy insight: cardiovascular complications associated with muscular dystrophies

Elizabeth M McNally1, Heather MacLeod

  • 1Department of Medicine, University of Chicago, IL 60637, USA. emcnally@medicine.bsd.uchicago.edu

Nature Clinical Practice. Cardiovascular Medicine
|November 3, 2005
PubMed

Insights

Muscular dystrophies often cause heart problems like cardiomyopathy. Emerging skeletal muscle therapies may improve heart function and patient longevity.

Area of Science:

  • Cardiovascular Medicine
  • Neuromuscular Disorders
  • Genetics

Background:

  • Muscular dystrophies frequently lead to serious cardiovascular complications, such as cardiomyopathy and arrhythmias.
  • These cardiac issues stem from intrinsic cardiomyocyte defects, conduction system dysfunction, and the impact of severe skeletal muscle disease.
  • While skeletal muscle degeneration has limited treatment options, cardiovascular complications are treatable.

Purpose of the Study:

  • To review the cardiovascular complications associated with muscular dystrophies.
  • To discuss current therapeutic strategies for cardiac issues in muscular dystrophy patients.
  • To explore the potential impact of novel skeletal muscle therapies on cardiac outcomes.

Main Methods:

  • Literature review of studies on muscular dystrophy and cardiovascular complications.
  • Analysis of current treatment guidelines for cardiac manifestations.
  • Examination of preclinical and clinical data on emerging skeletal muscle therapies.

Main Results:

  • Cardiovascular complications are a significant cause of morbidity and mortality in muscular dystrophy.
  • Existing therapies can manage cardiac dysfunction, improving patient well-being.
  • New skeletal muscle-targeting therapies show promise for improving cardiac function.

Conclusions:

  • Cardiovascular complications are integral to the management of muscular dystrophy.
  • Therapeutic advancements in skeletal muscle disease are anticipated to positively influence cardiac health.
  • Integrated treatment approaches are crucial for enhancing the longevity and quality of life for patients with muscular dystrophy.

More Related Videos

Immunolabelling Myofiber Degeneration in Muscle Biopsies06:37

Immunolabelling Myofiber Degeneration in Muscle Biopsies

Published on: December 5, 2019

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

Related Concept Videos

Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...